O	0	7	Effects
O	8	10	of
O	11	21	concurrent
B-intervention	22	29	aerobic
I-intervention	30	33	and
I-intervention	34	42	strength
I-intervention	43	51	training
O	52	54	on
O	55	61	breast
O	62	68	cancer
O	69	78	survivors
O	78	79	:
O	80	81	a
O	82	87	pilot
O	88	93	study
O	93	94	.

O	95	98	The
O	99	102	aim
O	103	105	of
O	106	109	the
O	110	115	study
O	116	119	was
O	120	122	to
O	123	131	evaluate
O	132	135	the
O	136	143	effects
O	144	146	of
O	147	148	a
O	149	157	combined
O	158	165	aerobic
O	166	169	and
O	170	178	strength
O	179	186	program
O	187	189	on
O	190	203	physiological
O	204	207	and
O	208	221	psychological
O	222	232	parameters
O	233	235	in
O	236	242	female
O	243	249	breast
O	250	256	cancer
O	257	266	survivors
O	266	267	.

O	268	278	Randomised
O	279	289	controlled
O	290	295	trial
O	295	296	.

B-total-participants	297	299	20
O	300	308	patients
O	309	310	(
O	310	313	age
O	313	314	:
B-age	315	317	45
I-age	317	318	.
I-age	318	319	6
I-age	320	321	Â±
I-age	322	323	2
I-age	323	324	.
I-age	324	325	7
I-age	326	329	yrs
O	329	330	)
B-eligibility	331	341	surgically
I-eligibility	342	349	treated
I-eligibility	350	353	for
I-eligibility	354	360	breast
I-eligibility	361	367	cancer
I-eligibility	368	372	that
I-eligibility	373	376	had
I-eligibility	377	386	completed
I-eligibility	387	390	all
I-eligibility	391	397	cancer
I-eligibility	398	407	therapies
I-eligibility	408	410	at
I-eligibility	411	416	least
I-eligibility	417	418	6
I-eligibility	419	425	months
I-eligibility	426	432	before
I-eligibility	433	436	and
I-eligibility	437	441	with
I-eligibility	442	444	no
I-eligibility	445	462	contraindications
I-eligibility	463	465	to
I-eligibility	466	474	physical
I-eligibility	475	483	activity
O	483	484	,
O	485	489	were
O	490	499	recruited
O	500	503	and
O	504	512	randomly
O	513	521	assigned
O	522	524	to
O	525	527	an
O	528	540	intervention
O	541	546	group
O	547	548	(
O	548	549	n
O	550	551	=
B-intervention-participants	552	554	10
O	554	555	)
O	556	559	and
O	560	561	a
B-control	562	569	control
I-control	570	575	group
O	576	577	(
O	577	578	n
O	579	580	=
B-control-participants	581	583	10
O	583	584	)
O	584	585	.

O	586	598	Intervention
O	599	604	group
O	605	613	patients
O	614	620	attend
O	621	623	to
O	624	625	a
O	626	628	24
O	628	629	-
O	629	633	week
O	634	642	combined
O	643	650	aerobic
O	651	654	and
O	655	663	strength
O	664	672	training
O	673	680	program
O	680	681	.

O	682	695	Physiological
O	696	697	(
O	697	698	i
O	698	699	.
O	700	701	e
O	701	702	.
O	703	709	VO2max
O	709	710	,
O	711	724	bioelectrical
O	725	734	impedance
O	735	739	test
O	739	740	,
O	741	748	maximal
O	749	757	strength
O	758	760	of
O	761	770	principal
O	771	779	muscular
O	780	786	groups
O	786	787	)
O	788	791	and
O	792	805	psychological
O	806	807	(
O	807	808	i
O	808	809	.
O	810	811	e
O	811	812	.
O	813	823	functional
O	824	834	assessment
O	835	837	of
O	838	845	chronic
O	846	853	illness
O	854	861	therapy
O	861	862	-
O	862	869	fatigue
O	869	870	:
O	871	876	FACIT
O	876	877	-
O	877	878	F
O	878	879	)
O	880	890	parameters
O	891	895	were
O	896	904	assessed
O	905	907	at
O	908	916	baseline
O	917	920	and
O	921	926	after
O	927	929	24
O	930	935	weeks
O	935	936	.

O	937	942	After
O	943	945	24
O	946	951	weeks
O	952	955	the
O	956	968	intervention
O	969	974	group
O	975	981	showed
O	982	993	significant
O	994	1005	improvement
O	1006	1008	in
B-outcome	1009	1015	VO2max
O	1016	1017	(
O	1017	1019	38
O	1019	1020	.
O	1020	1021	8
O	1021	1022	%
O	1022	1023	)
O	1023	1024	,
B-outcome	1025	1033	strength
I-outcome	1034	1036	of
I-outcome	1037	1042	upper
I-outcome	1043	1046	and
I-outcome	1047	1052	lower
I-outcome	1053	1058	limbs
O	1059	1060	(
O	1060	1067	ranging
O	1068	1072	from
O	1073	1075	13
O	1076	1078	to
O	1079	1081	60
O	1081	1082	%
O	1082	1083	)
O	1084	1087	and
O	1088	1096	decrease
O	1097	1099	in
B-outcome	1100	1103	fat
I-outcome	1104	1108	mass
I-outcome	1109	1119	percentage
O	1120	1121	(
O	1121	1122	-
O	1122	1123	6
O	1123	1124	.
O	1124	1125	3
O	1125	1126	%
O	1126	1127	)
O	1127	1128	.

O	1129	1132	The
O	1133	1138	FACIT
O	1138	1139	-
O	1139	1140	F
O	1141	1147	showed
O	1148	1159	significant
O	1160	1168	increase
O	1169	1171	in
O	1172	1175	all
O	1176	1178	of
O	1179	1182	the
O	1183	1188	three
O	1189	1195	scores
O	1196	1200	that
O	1201	1204	can
O	1205	1207	be
O	1208	1215	derived
O	1216	1217	(
B-outcome	1217	1222	FACIT
I-outcome	1222	1223	-
I-outcome	1223	1224	F
I-outcome	1225	1230	Trial
I-outcome	1231	1238	outcome
O	1238	1239	:
O	1240	1242	13
O	1242	1243	%
O	1243	1244	;
B-outcome	1245	1249	FACT
I-outcome	1249	1250	-
I-outcome	1250	1251	G
I-outcome	1252	1257	total
I-outcome	1258	1263	score
O	1263	1264	:
O	1265	1267	18
O	1267	1268	%
O	1268	1269	;
B-outcome	1270	1275	FACIT
I-outcome	1275	1276	-
I-outcome	1276	1277	F
I-outcome	1278	1283	total
I-outcome	1284	1289	score
O	1289	1290	:
O	1291	1293	15
O	1293	1294	%
O	1294	1295	)
O	1296	1303	showing
O	1304	1311	patient
O	1311	1312	'
O	1312	1313	s
B-outcome	1314	1321	quality
I-outcome	1322	1324	of
I-outcome	1325	1329	life
I-outcome	1330	1331	(
I-outcome	1331	1334	QOL
I-outcome	1334	1335	)
O	1336	1347	improvement
O	1347	1348	.

O	1349	1351	No
O	1352	1363	significant
O	1364	1370	change
O	1371	1373	in
O	1374	1377	all
O	1378	1381	the
O	1382	1392	parameters
O	1393	1396	was
O	1397	1402	found
O	1403	1406	for
O	1407	1410	the
O	1411	1418	control
O	1419	1424	group
O	1424	1425	.

O	1426	1431	These
O	1432	1439	results
O	1440	1444	show
O	1445	1448	the
O	1449	1457	positive
O	1458	1465	effects
O	1466	1468	of
O	1469	1470	a
O	1471	1479	combined
O	1480	1487	aerobic
O	1488	1491	and
O	1492	1500	strength
O	1501	1509	training
O	1510	1517	program
O	1518	1520	on
O	1521	1527	breast
O	1528	1534	cancer
O	1535	1544	survivors
O	1545	1548	and
O	1549	1558	underline
O	1559	1562	the
O	1563	1573	importance
O	1574	1576	of
O	1577	1580	the
O	1581	1586	early
O	1587	1596	inclusion
O	1597	1599	of
O	1600	1610	structured
O	1611	1619	physical
O	1620	1628	activity
O	1629	1631	in
O	1632	1635	the
O	1636	1650	rehabilitation
O	1651	1659	protocol
O	1659	1660	.
